Wednesday, October 14, 2026

Tempur Sealy International And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Tempur Sealy International  And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) - Overstock.com (OSTK), Tempur Sealy International (TPX), American Electric Power Company (AEP) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Overstock.com (OSTK)

22.1% sales growth and 28.15% return on equity

Overstock.com, Inc. operates as an online retailer in the United States.

Overstock.com's sales growth this year is expected to be 10.9% and 11.9% for next year.

Year-on-year quarterly revenue growth grew by 94.3%, now sitting on 2.87B for the twelve trailing months.

Volume

Today's last reported volume for Overstock.com is 1110750 which is 33.69% below its average volume of 1675030.

Overstock.com's sales growth for the next quarter is 22.1%. The company's growth estimates for the ongoing quarter and the next is a negative 34.4% and negative -12%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 28.15%.

Volatility

Overstock.com's last day, last week, and last month's current volatility was 4.81%, 5.53%, and 4.81%, respectively.

Overstock.com's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 8.56% (day), 7.32% (last week), and 7.39% (last month), respectively.

Overstock.com's Stock Yearly Top and Bottom Value

Overstock.com's stock is valued at $82.50 at 17:22 EST, way below its 52-week high of $128.50 and way above its 52-week low of $44.63.

Overstock.com's Moving Average

Overstock.com's value is under its 50-day moving average of $90.50 and above its 200-day moving average of $77.43.

2. Tempur Sealy International (TPX)

10.1% sales growth and 156.72% return on equity

Tempur Sealy International, Inc., together with its subsidiaries, develops, manufactures, markets, and distributes bedding products in the United States, Canada, and internationally.

Tempur Sealy International's sales growth this year is anticipated to be 26.1% and 7.6% for next year.

Year-on-year quarterly revenue growth grew by 26.9%, now sitting on 3.9B for the twelve trailing months.

Volume

Today's last reported volume for Tempur Sealy International is 1027270 which is 44.83% below its average volume of 1861940.

Tempur Sealy International's sales growth for the next quarter is 10.1%. The company's growth estimates for the ongoing quarter and the next is 229.4% and 12.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 156.72%.

Volatility

Tempur Sealy International's last day, last week, and last month's current volatility was 7.06%, 2.54%, and 2.13%, respectively.

Tempur Sealy International's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.98% (day), 2.89% (last week), and 3.09% (last month), respectively.

Tempur Sealy International's Stock Yearly Top and Bottom Value

Tempur Sealy International's stock is valued at $39.47 at 17:22 EST, below its 52-week high of $42.60 and way above its 52-week low of $18.06.

Tempur Sealy International's Moving Average

Tempur Sealy International's value is above its 50-day moving average of $38.93 and way above its 200-day moving average of $35.46.

3. American Electric Power Company (AEP)

6.6% sales growth and 11.02% return on equity

American Electric Power Company, Inc., an electric public utility holding company, engages in the generation, transmission, and distribution of electricity for sale to retail and wholesale customers in the United States.

American Electric Power Company's sales growth this year is expected to be 9.2% and 4% for next year.

Year-on-year quarterly revenue growth grew by 14.2%, now sitting on 15.45B for the twelve trailing months.

Volume

Today's last reported volume for American Electric Power Company is 2162670 which is 21.25% below its average volume of 2746360.

American Electric Power Company's sales growth for the next quarter is 6.6%. The company's growth estimates for the present quarter and the next is 4.6% and 1.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.02%.

Volatility

American Electric Power Company's last day, last week, and last month's current volatility was 1.16%, 0.51%, and 0.68%, respectively.

American Electric Power Company's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.03% (day), 1.44% (last week), and 1.51% (last month), respectively.

American Electric Power Company's Stock Yearly Top and Bottom Value

American Electric Power Company's stock is valued at $87.49 at 17:22 EST, below its 52-week high of $94.21 and way higher than its 52-week low of $74.80.

American Electric Power Company's Moving Average

American Electric Power Company's worth is above its 50-day moving average of $84.84 and higher than its 200-day moving average of $83.51.

4. Pepsico (PEP)

6.4% sales growth and 54.66% return on equity

PepsiCo, Inc. operates as a food and beverage company worldwide.

Pepsico's sales growth this year is expected to be 7.2% and 4.6% for next year.

Year-on-year quarterly revenue growth grew by 6.8%, now sitting on 71.31B for the twelve trailing months.

Volume

Today's last reported volume for Pepsico is 5192960 which is 3.32% above its average volume of 5025910.

Pepsico's sales growth for the next quarter is 6.4%. The company's growth estimates for the current quarter and the next is 15.2% and 5.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 54.66%.

Volatility

Pepsico's last day, last week, and last month's current volatility was 0.46%, 0.81%, and 0.63%, respectively.

Pepsico's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.37% (day), 1.29% (last week), and 1.06% (last month), respectively.

Pepsico's Stock Yearly Top and Bottom Value

Pepsico's stock is valued at $155.82 at 17:22 EST, below its 52-week high of $156.84 and way higher than its 52-week low of $128.32.

Pepsico's Moving Average

Pepsico's value is above its 50-day moving average of $148.22 and above its 200-day moving average of $142.37.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,372 source documents archived
Query this data → isubstrate.com